Firefly Neuroscience (NASDAQ: AIFF) has achieved a major operational and commercial milestone with more than 200,000 EEG/ERP (human brain function) scans.
Through its acquisition of Evoke Neuroscience in May 2025, combined with the successful execution of its key internal growth initiatives, Firefly has now driven 5%, 11%, 15%, and 17% sequential EEG/ERP brain scan volume growth, respectively, over the past four quarters.
In a statement, Greg Lipschitz, CEO of Firefly, commented, “Surpassing this important milestone opens the door to us potentially making additional new breakthroughs in cognitive brain biomarker discovery, building upon those we’ve already recently made for differential diagnosis of ADHD, objective measurement of SCD/MCI/Dementia in Alzheimer’s patients, and cognitive assessment of brain age. In so doing, we also believe we are now much closer to fulfilling our goal of building and launching the world’s first EEG/ERP-based foundation model of the human brain.”
Firefly is harnessing increased data and NVIDIA L40S GPU acceleration to power next-generation EEG/ERP processing, enabling new AI-driven biomarker discovery capabilities.
